Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

August 30, 2024
Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared HolzUpside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho’s Jared Holz

Jared Holz, Mizuho, joins ‘Fast Money’ to talk opportunities in pharma investing following approval of Emergent Bio’s Mpox vaccine.


 

Share This

Latest Mizuho News

See all news
Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

March 20, 2026
Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

March 13, 2026
Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

March 17, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue